{
    "Trade/Device Name(s)": [
        "iHealth Wireless Smart Gluco-Monitoring System (BG5)"
    ],
    "Submitter Information": "Andon Health Co., Ltd.",
    "510(k) Number": "K153278",
    "Predicate Device Reference 510(k) Number(s)": [
        "K123935"
    ],
    "Regulatory Class": "Class II, Class I",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JQP"
    ],
    "Summary Letter Date": "August 11, 2016",
    "Summary Letter Received Date": "August 15, 2016",
    "Submission Date": "November 5, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.2100"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Blood Glucose Monitoring System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "iHealth Wireless Glucose meter (BG5)",
        "Compatible Android or iOS mobile device"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Amperometry",
        "Glucose Oxidase"
    ],
    "Methodologies": [
        "In vitro diagnostic",
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Mobile Application",
        "Lancet",
        "Lancing Device",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for iHealth Wireless Smart Gluco-Monitoring System (BG5) for self-testing blood glucose using electrochemical biosensor technology with Android/iOS connectivity",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood drawn from various body sites by people with diabetes at home for self-testing and monitoring effectiveness of diabetes control; not for diagnosis, screening, or neonatal use",
    "fda_folder": "Clinical Chemistry"
}